Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Q-Med Aktiebolag
AB
Active
Org 5562586882
Seminariegatan 21, 752 28
Uppsala
Manufacture of basic pharmaceutical products
· NACE 2110
Est. 1985
589 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of basic pharmaceutical products
/
Q-Med Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
526M
1B
2B
2B
1.3B
2020
1.4B
2021
1.5B
2022
1.5B
2023
1.8B
2024
EBITDA
SEK millions
0M
110M
219M
329M
438M
196M
2020
229M
2021
313M
2022
234M
2023
381M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
1 312 272
1 401 073
1 473 106
1 502 559
1 828 337
Staff expenses
—
—
—
—
—
EBITDA
195 645
228 858
313 085
233 584
380 842
Depreciation & amort.
—
—
—
—
—
EBIT
195 645
228 858
313 085
233 584
380 842
Net financials
−8 134
7 660
11 818
24 100
−60 722
Profit before tax
205 355
220 883
552 869
254 531
273 533
Tax
−252 369
−44 520
−108 589
−35 734
−51 724
Net profit
−47 014
176 363
444 280
218 797
221 809
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 645 942
1 847 409
2 343 656
3 233 002
4 130 237
Equity
239 166
415 529
859 809
1 078 606
1 300 415
Long-term debt
0
0
341 000
1 027 000
1 493 000
Short-term debt
385 052
392 770
427 379
433 116
594 988
Total debt
385 052
392 770
768 379
1 460 116
2 087 988
Financial ratios
5-year trend
EBITDA margin
20.8%
This company
15.8%
Market median
+32% vs market
2020
2024
Equity ratio
31.5%
This company
38.2%
Market median
+18% vs market
2020
2024
Return on equity
17.1%
This company
18.4%
Market median
+7% vs market
2020
2024
Net profit margin
12.1%
This company
8.1%
Market median
+49% vs market
2020
2024
Asset turnover
0.44×
This company
1.12×
Market median
-61% vs market
2020
2024
Debt / equity
2.18×
This company
0.62×
Market median
-252% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Q-Med Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
